ADNI | Publications

Filter results by:

3740 Total Publications

The executive prominent/memory prominent spectrum in Alzheimer’s disease is highly heritable
J. Mez, S. Mukherjee, T. Thornton, D. W. Fardo, E. Trittschuh, S. Sutti, R. Sherva, J. S. Kauwe, A. C. Naj, G. W. Beecham, A. Gross, A. J. Saykin, R. C. Green, P. K. Crane, G. Executive Prominent Alzheimer's Disease, F. Risk, I. Alzheimer's Disease Neuroimaging and C. Alzheimer's Disease Genetics
PMID: 27103524 ; PMCID:4843522 ; 2016; Journal Neurobiol Aging; vol. 41; pp. 115-121; doi:10.1016/j.neurobiolaging.2016.02.015

Linear and Curvilinear Trajectories of Cortical Loss with Advancing Age and Disease Duration in Parkinson’s Disease
D. O. Claassen, D. G. Dobolyi, D. A. Isaacs, O. C. Roman, J. Herb, S. A. Wylie, J. S. Neimat, M. J. Donahue, P. Hedera, D. H. Zald, B. A. Landman, A. B. Bowman, B. M. Dawant and S. Rane
PMID: 27330836 ; PMCID:4898918 ; 2016; Journal Aging Dis; vol. 7; no. 3; pp. 220-9; doi:10.14336/AD.2015.1110

False-Positive Error Rates for Reliable Digit Span and Auditory Verbal Learning Test Performance Validity Measures in Amnestic Mild Cognitive Impairment and Early Alzheimer Disease
D. W. Loring, F. C. Goldstein, C. Chen, D. L. Drane, J. J. Lah, L. Zhao, G. J. Larrabee and I. Alzheimer's Disease Neuroimaging
PMID: 27084732 ; PMCID:4876935 ; 2016; Journal Arch Clin Neuropsychol; vol. 31; no. 4; pp. 313-31; doi:10.1093/arclin/acw014

Anti-Correlated Cerebrospinal Fluid Biomarker Trajectories in Preclinical Alzheimer's Disease.
J. J. Gomar, C. Conejero-Goldberg, P. Davies, T. E. Goldberg and I. Alzheimer's Disease Neuroimaging
PMID: 26967213 ; 2016; Journal J Alzheimers Dis; vol. 51; no. 4; pp. 1085-97; doi:10.3233/JAD-150937

Enhanced resting-state functional connectivity between core memory-task activation peaks is associated with memory impairment in MCI
Y. Zhang, L. Simon-Vermot, M. A. Araque Caballero, B. Gesierich, A. N. W. Taylor, M. Duering, M. Dichgans, M. Ewers and I. Alzheimer's Disease Neuroimaging
PMID: 27459924 ; 2016; Journal Neurobiol Aging; vol. 45; pp. 43-49; doi:10.1016/j.neurobiolaging.2016.04.018

Enrichment of clinical trials in MCI due to AD using markers of amyloid and neurodegeneration
R. Wolz, A. J. Schwarz, K. R. Gray, P. Yu, D. L. Hill and I. Alzheimer's Disease Neuroimaging
PMID: 27558378 ; PMCID:5035986 ; 2016; Journal Neurology; vol. 87; no. 12; pp. 1235-41; doi:10.1212/WNL.0000000000003126

Domain Adaptation for Alzheimer’s Disease Diagnostics
C. Wachinger, M. Reuter, I. Alzheimer's Disease Neuroimaging, B. Australian Imaging and a. Lifestyle flagship study of
PMID: 27262241 ; PMCID:4983466 ; 2016; Journal Neuroimage; vol. 139; pp. 470-479; doi:10.1016/j.neuroimage.2016.05.053

Reference tissue normalization in longitudinal (18)F-florbetapir positron emission tomography of late mild cognitive impairment
S. Shokouhi, J. W. McKay, S. L. Baker, H. Kang, A. B. Brill, H. E. Gwirtsman, W. R. Riddle, D. O. Claassen, B. P. Rogers and I. Alzheimer's Disease Neuroimaging
PMCID:4714472 ; 2016; Journal Alzheimers Res Ther; vol. 8; no. 1; pp. 2; doi:10.1186/s13195-016-0172-3

Two-dimensional Enrichment Analysis for Mining High-level Imaging Genetic Associations
X. Yao, J. Yan, S. Kim, K. Nho, S. L. Risacher, M. Inlow, J. H. Moore, A. J. Saykin and L. Shen
PMID: 26568986 ; PMCID:4640356 ; 2016; Journal Brain Inform; vol. 4; no. 1; pp. 27-37; doi:10.1007/s40708-016-0052-4

Normative data for subcortical regional volumes over the lifetime of the adult human brain
O. Potvin, A. Mouiha, L. Dieumegarde, S. Duchesne and I. Alzheimer's Disease Neuroimaging
2016; Journal Neuroimage; vol. 137; pp. 20-Sep; doi:10.1016/j.neuroimage.2016.05.016